Diatreme Resources
Logotype for Diatreme Resources Limited

Diatreme Resources (DRX) investor relations material

Diatreme Resources Q3 2026 TU earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Diatreme Resources Limited
Q3 2026 TU earnings summary29 Oct, 2026

Executive summary

  • Post-quarter PFS outlined a 25-year Northern Silica Project (NSP), with a 3 Mtpa base case and a potential 5 Mtpa expansion from Year 3.

  • The Cape Flattery Silica Project sale to the DRX/Sibelco joint venture generated total funding of ~$7.4 million; the resulting joint venture interest is 73.2%.

  • September-quarter-end cash was $1.919 million, with a further $6.9 million held in the silica joint venture; combined cash was $8.8 million.

Financial highlights

  • Half-year net loss to 30 June 2026 was $3.025 million, versus a $0.728 million loss in 2025.

  • Q3 net operating cash outflow was $684,000; investing outflow was $114,000 and financing outflow was $17,000.

  • Nine-month net operating cash outflow was $2.041 million; cash and cash equivalents closed at $1.919 million.

Outlook and guidance

  • PFS Phase 1 base case: 3 Mtpa over 25 years, with pre-tax NPV of $1.290 billion, pre-tax IRR of 36%, and four-year payback.

  • Potential Phase 2 from Year 3 lifts production to 5 Mtpa; PFS estimates pre-tax NPV of $2.419 billion and pre-tax IRR of 46%, with $38.5 million additional capex.

  • Definitive Feasibility Study (DFS) completion is targeted for Q2/Q3 CY2028, with Final Investment Decision (FID) targeted for Q3 CY2028.

  • December-quarter priorities include NSP permitting, port-access negotiations and Traditional Owner agreement discussions; Cyclone options include sale, joint venture or asset spin-out.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.
Diatreme Resources
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

Diatreme Resources Limited is an Australian mining and exploration company focused on the development of mineral sands and silica sand projects. The company’s primary asset is the Galalar Silica Project in Queensland, which targets high-purity silica sand, a key material used in industries such as glass manufacturing, solar panels, and electronics. Diatreme Resources also explores for mineral sands containing valuable heavy minerals, such as zircon and titanium, which are used for various industrial applications. Diatreme Resources Limited is headquartered in Brisbane, Australia, and its shares are listed on the ASX.